FDA.reportPublic FDA data

XELJANZ

Product NDC
0069-1029
11-digit product format
000691029
Labeler code
0069
Product ID
0069-1029_39aa36a4-7b51-43af-9bf0-d812b3f9bd1d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
tofacitinib
Dosage form
SOLUTION
Route
ORAL
Labeler
Pfizer Laboratories Div Pfizer Inc
Application
NDA213082
Marketing category
NDA
Marketing start
2021-02-08
Substance
TOFACITINIB CITRATE
Active strength
1 mg/mL
Pharmacologic classes
Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
XELJANZ
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TOFACITINIB CITRATE1 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiO1FF4DIV0D
Rxcui1357541, 1357547, 1741046, 1741049, 2048566, 2048568, 2273113, 2273115, 2478433, 2478437

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
10e4c2fb-ffa2-728d-14d9-1c6c2f2b27b6Product name420250623
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0069-1029-01XELJANZ240 mL in 1 BOTTLESOLUTION24053
0069-1029-02XELJANZ1 in 1 CARTONSOLUTION153

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0069-1029-01ML - Milliliter0069-1029e8f5459b-9e04-49e2-9207-b8563b645f0a12021-03-02
0069-1029-02ML - Milliliter0069-1029ab3afb2e-c7a8-4c8c-b7d7-2c29d2947f5212021-03-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
TOFACITINIB CITRATEACTIVE INGREDIENTO1FF4DIV0DXELJANZ (TOFACITINIB) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]12
TOFACITINIBACTIVE MOIETY87LA6FU830XELJANZ (TOFACITINIB) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]12
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UXELJANZ (TOFACITINIB) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]12
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48XELJANZ (TOFACITINIB) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]12
HYPROMELLOSE 2910 (6 MPA.S)INACTIVE INGREDIENT0WZ8WG20P6XELJANZ (TOFACITINIB) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]12
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XXELJANZ (TOFACITINIB) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]12
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30XELJANZ (TOFACITINIB) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]12
POLYETHYLENE GLYCOL 3350INACTIVE INGREDIENTG2M7P15E5PXELJANZ (TOFACITINIB) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]12
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPXELJANZ (TOFACITINIB) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]12
TRIACETININACTIVE INGREDIENTXHX3C3X673XELJANZ (TOFACITINIB) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0069-1029XELJANZ (TOFACITINIB) TABLET, FILM COATED XELJANZ XR (TOFACITINIB) TABLET, FILM COATED, EXTENDED RELEASE XELJANZ (TOFACITINIB) SOLUTION [PFIZER LABORATORIES DIV PFIZER INC]49Current NDC, Legacy NDC, 2 package rows20241222_cf74ba2f-afc5-4baa-8594-979c889a5831.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2478433tofacitinib 1 MG/mL Oral SolutionPSNcf74ba2f-afc5-4baa-8594-979c889a583153
2048566tofacitinib 10 MG Oral TabletPSNcf74ba2f-afc5-4baa-8594-979c889a583153
1741046tofacitinib 11 MG 24HR Extended Release Oral TabletPSNcf74ba2f-afc5-4baa-8594-979c889a583153
2273113tofacitinib 22 MG 24HR Extended Release Oral TabletPSNcf74ba2f-afc5-4baa-8594-979c889a583153
1357541tofacitinib 5 MG Oral TabletPSNcf74ba2f-afc5-4baa-8594-979c889a583153
2478437Xeljanz 1 MG/mL Oral SolutionPSNcf74ba2f-afc5-4baa-8594-979c889a583153
2048568Xeljanz 10 MG Oral TabletPSNcf74ba2f-afc5-4baa-8594-979c889a583153
1357547Xeljanz 5 MG Oral TabletPSNcf74ba2f-afc5-4baa-8594-979c889a583153
1741049Xeljanz XR 11 MG 24HR Extended Release Oral TabletPSNcf74ba2f-afc5-4baa-8594-979c889a583153
2273115Xeljanz XR 22 MG 24HR Extended Release Oral TabletPSNcf74ba2f-afc5-4baa-8594-979c889a583153
174104924 HR tofacitinib 11 MG Extended Release Oral Tablet [Xeljanz]SBDcf74ba2f-afc5-4baa-8594-979c889a583153
227311524 HR tofacitinib 22 MG Extended Release Oral Tablet [Xeljanz]SBDcf74ba2f-afc5-4baa-8594-979c889a583153
2478437tofacitinib 1 MG/ML Oral Solution [Xeljanz]SBDcf74ba2f-afc5-4baa-8594-979c889a583153
2048568tofacitinib 10 MG Oral Tablet [Xeljanz]SBDcf74ba2f-afc5-4baa-8594-979c889a583153
1357547tofacitinib 5 MG Oral Tablet [Xeljanz]SBDcf74ba2f-afc5-4baa-8594-979c889a583153
174104624 HR tofacitinib 11 MG Extended Release Oral TabletSCDcf74ba2f-afc5-4baa-8594-979c889a583153
227311324 HR tofacitinib 22 MG Extended Release Oral TabletSCDcf74ba2f-afc5-4baa-8594-979c889a583153
2478433tofacitinib 1 MG/ML Oral SolutionSCDcf74ba2f-afc5-4baa-8594-979c889a583153
2048566tofacitinib 10 MG Oral TabletSCDcf74ba2f-afc5-4baa-8594-979c889a583153
1357541tofacitinib 5 MG Oral TabletSCDcf74ba2f-afc5-4baa-8594-979c889a583153
2048566tofacitinib 10 MG (as tofacitinib citrate 16 MG) Oral TabletSYcf74ba2f-afc5-4baa-8594-979c889a583153
1741046tofacitinib 11 MG (as tofacitinib citrate 17.77 MG) 24 HR Extended Release Oral TabletSYcf74ba2f-afc5-4baa-8594-979c889a583153
1741046tofacitinib 11 MG 24 HR Extended Release Oral TabletSYcf74ba2f-afc5-4baa-8594-979c889a583153
1357541tofacitinib 5 MG (as tofacitinib citrate 8 MG) Oral TabletSYcf74ba2f-afc5-4baa-8594-979c889a583153
2478437Xeljanz 1 MG/ML Oral SolutionSYcf74ba2f-afc5-4baa-8594-979c889a583153
2048568Xeljanz 10 MG (as tofacitinib citrate 16 MG) Oral TabletSYcf74ba2f-afc5-4baa-8594-979c889a583153
2048568Xeljanz 10 MG Oral TabletSYcf74ba2f-afc5-4baa-8594-979c889a583153
1357547Xeljanz 5 MG (as tofacitinib citrate 8 MG) Oral TabletSYcf74ba2f-afc5-4baa-8594-979c889a583153
1357547Xeljanz 5 MG Oral TabletSYcf74ba2f-afc5-4baa-8594-979c889a583153
1741049Xeljanz XR 11 MG (as tofacitinib citrate 17.77 MG) 24 HR Extended Release Oral TabletSYcf74ba2f-afc5-4baa-8594-979c889a583153
1741049Xeljanz XR 11 MG 24 HR Extended Release Oral TabletSYcf74ba2f-afc5-4baa-8594-979c889a583153
2273115Xeljanz XR 22 MG (as tofacitinib citrate 35.54 MG) 24 HR Extended Release Oral TabletSYcf74ba2f-afc5-4baa-8594-979c889a583153

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0069-1029-0100069102901240 mL in 1 BOTTLE240 mlHistorical
0069-1029-02000691029021 BOTTLE in 1 CARTON (0069-1029-02) / 240 mL in 1 BOTTLE (0069-1029-01) 1 bottle2021-02-080000-00-00NoNoCurrent